
    
      This study will evaluate the efficacy of IRay treatment in patients with Vascularized Pigment
      Epithelial Detachment (V-PED) with serous component superior to 50% of the lesion as
      determined by decreasing the lesion activity; by decreasing the number of Lucentis injections
      required during the 12 month study.
    
  